Развитие клеточных и генетических технологий в России
Эффективное здравоохранение
15 января 2020, 11:30 – 13:30, 5 корпус, 5 этаж, Зал заседаний
Поделиться
В настоящее время в мире происходит стремительное развитие генетических, клеточных и геномных технологий в здравоохранении, включая активное внедрение в клиническую практику генотерапевтических и клеточных препаратов, действие которых направлено на причину возникновения заболевания. Появление такого класса препаратов позволило эффективно бороться с заболеваниями, которые ранее считались неизлечимыми.
Введение в практику и применение инновационных генотерапевтических и клеточных технологий в России затруднено по ряду следующих причин: сложный процесс регистрации, ограниченный доступ пациентов к генетическим методам диагностики, несовершенная система оплаты медицинской помощи. Успешное внедрение инновационных технологий возможно только при активном диалоге между государством и производителем для адаптации нормативно-правового регулирования и дальнейшего обеспечения доступности для пациентов.
Вопросы для обсуждения
Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.
Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.
директор Департамента науки, инновационного развития и управления медико- биологическими рисками здоровью Министерства здравоохранения Российской Федерации
начальник отдела координации работ в сфере обращения лекарственных средств и медицинских изделий Департамента технического регулирования и аккредитации ЕЭК
директор по медицинским вопросам на развивающихся рынках региона EMEA, Янссен
Array
(
[ACTIVE_TO] => 15.01.2020 13:30:00
[~ACTIVE_TO] => 15.01.2020 13:30:00
[ACTIVE_FROM] => 15.01.2020 11:30:00
[~ACTIVE_FROM] => 15.01.2020 11:30:00
[ID] => 20567
[~ID] => 20567
[NAME] => Развитие клеточных и генетических технологий в России
[~NAME] => Развитие клеточных и генетических технологий в России
[IBLOCK_ID] => 9
[~IBLOCK_ID] => 9
[IBLOCK_SECTION_ID] => 353
[~IBLOCK_SECTION_ID] => 353
[DETAIL_TEXT] =>
[~DETAIL_TEXT] =>
[DETAIL_TEXT_TYPE] => html
[~DETAIL_TEXT_TYPE] => html
[PREVIEW_TEXT] =>
В настоящее время в мире происходит стремительное развитие генетических, клеточных и геномных технологий в здравоохранении, включая активное внедрение в клиническую практику генотерапевтических и клеточных препаратов, действие которых направлено на причину возникновения заболевания. Появление такого класса препаратов позволило эффективно бороться с заболеваниями, которые ранее считались неизлечимыми.
Введение в практику и применение инновационных генотерапевтических и клеточных технологий в России затруднено по ряду следующих причин: сложный процесс регистрации, ограниченный доступ пациентов к генетическим методам диагностики, несовершенная система оплаты медицинской помощи. Успешное внедрение инновационных технологий возможно только при активном диалоге между государством и производителем для адаптации нормативно-правового регулирования и дальнейшего обеспечения доступности для пациентов.
[~PREVIEW_TEXT] =>
В настоящее время в мире происходит стремительное развитие генетических, клеточных и геномных технологий в здравоохранении, включая активное внедрение в клиническую практику генотерапевтических и клеточных препаратов, действие которых направлено на причину возникновения заболевания. Появление такого класса препаратов позволило эффективно бороться с заболеваниями, которые ранее считались неизлечимыми.
Введение в практику и применение инновационных генотерапевтических и клеточных технологий в России затруднено по ряду следующих причин: сложный процесс регистрации, ограниченный доступ пациентов к генетическим методам диагностики, несовершенная система оплаты медицинской помощи. Успешное внедрение инновационных технологий возможно только при активном диалоге между государством и производителем для адаптации нормативно-правового регулирования и дальнейшего обеспечения доступности для пациентов.
[PREVIEW_TEXT_TYPE] => html
[~PREVIEW_TEXT_TYPE] => html
[DETAIL_PICTURE] =>
[~DETAIL_PICTURE] =>
[TIMESTAMP_X] => 21.01.2020 12:59:29
[~TIMESTAMP_X] => 21.01.2020 12:59:29
[LIST_PAGE_URL] => /program/
[~LIST_PAGE_URL] => /program/
[DETAIL_PAGE_URL] => /program/15-yanvarya/razvitie-kletochnykh-i-geneticheskikh-tekhnologiy-v-rossii/
[~DETAIL_PAGE_URL] => /program/15-yanvarya/razvitie-kletochnykh-i-geneticheskikh-tekhnologiy-v-rossii/
[LANG_DIR] => /
[~LANG_DIR] => /
[CODE] => razvitie-kletochnykh-i-geneticheskikh-tekhnologiy-v-rossii
[~CODE] => razvitie-kletochnykh-i-geneticheskikh-tekhnologiy-v-rossii
[EXTERNAL_ID] => 20567
[~EXTERNAL_ID] => 20567
[IBLOCK_TYPE_ID] => content
[~IBLOCK_TYPE_ID] => content
[IBLOCK_CODE] => program
[~IBLOCK_CODE] => program
[IBLOCK_EXTERNAL_ID] => 9
[~IBLOCK_EXTERNAL_ID] => 9
[LID] => s1
[~LID] => s1
[NAV_RESULT] =>
[DISPLAY_ACTIVE_FROM] => 15 Января 2020
[IPROPERTY_VALUES] => Array
(
)
[FIELDS] => Array
(
[ACTIVE_TO] => 15.01.2020 13:30:00
[ACTIVE_FROM] => 15.01.2020 11:30:00
)
[PROPERTIES] => Array
(
[QUESTIONS] => Array
(
[ID] => 12
[TIMESTAMP_X] => 2017-12-18 10:54:36
[IBLOCK_ID] => 9
[NAME] => Вопросы для обсуждения
[ACTIVE] => Y
[SORT] => 10
[CODE] => QUESTIONS
[DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 12
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => Y
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] => HTML
[USER_TYPE_SETTINGS] => Array
(
[height] => 200
)
[HINT] =>
[PROPERTY_VALUE_ID] => 112126
[VALUE] => Array
(
[TEXT] => <ul class="style-prog-list">
<li>Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.</li>
<li>Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.</li>
</ul>
[TYPE] => HTML
)
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Array
(
[TEXT] =>
Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.
Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.
[TYPE] => HTML
)
[~DESCRIPTION] =>
[~NAME] => Вопросы для обсуждения
[~DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
)
[TYPE] => Array
(
[ID] => 13
[TIMESTAMP_X] => 2017-12-18 10:54:36
[IBLOCK_ID] => 9
[NAME] => Тип мероприятия
[ACTIVE] => Y
[SORT] => 20
[CODE] => TYPE
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 13
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 138115
[VALUE] => Экспертная дискуссия
[DESCRIPTION] =>
[VALUE_ENUM] => Экспертная дискуссия
[VALUE_XML_ID] => 2
[VALUE_SORT] => 200
[VALUE_ENUM_ID] => 2
[~VALUE] => Экспертная дискуссия
[~DESCRIPTION] =>
[~NAME] => Тип мероприятия
[~DEFAULT_VALUE] =>
)
[LOCATION] => Array
(
[ID] => 19
[TIMESTAMP_X] => 2017-12-18 10:54:36
[IBLOCK_ID] => 9
[NAME] => Место проведения мероприятия
[ACTIVE] => Y
[SORT] => 30
[CODE] => LOCATION
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 19
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 112138
[VALUE] => 5 корпус, 5 этаж, Зал заседаний
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => 5 корпус, 5 этаж, Зал заседаний
[~DESCRIPTION] =>
[~NAME] => Место проведения мероприятия
[~DEFAULT_VALUE] =>
)
[MODERATORS] => Array
(
[ID] => 14
[TIMESTAMP_X] => 2017-12-18 13:54:45
[IBLOCK_ID] => 9
[NAME] => Модераторы
[ACTIVE] => Y
[SORT] => 40
[CODE] => MODERATORS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 14
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => Array
(
[0] => 112128
)
[VALUE] => Array
(
[0] => Array
(
[ID] => 15467
[NAME] => Виталий Омельяновский
[DETAIL_PAGE_URL] => /experts/vitalij-omelyanovskij5325/
[POSITION] => генеральный директор Центра экспертизы и контроля качества медицинской помощи Министерства здравоохранения Российской Федерации
[DONOTLINK] =>
[PREVIEW_PICTURE] => 36683
)
)
[DESCRIPTION] => Array
(
[0] =>
)
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Array
(
[0] => 15467
)
[~DESCRIPTION] => Array
(
[0] =>
)
[~NAME] => Модераторы
[~DEFAULT_VALUE] =>
)
[KEYREPORTS] => Array
(
[ID] => 65
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Ключевой доклад / Ключевые доклады
[ACTIVE] => Y
[SORT] => 50
[CODE] => KEYREPORTS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 65
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Ключевой доклад / Ключевые доклады
[~DEFAULT_VALUE] =>
)
[KEYREPORT2S] => Array
(
[ID] => 283
[TIMESTAMP_X] => 2019-01-04 22:39:47
[IBLOCK_ID] => 9
[NAME] => Ключевые выступления
[ACTIVE] => Y
[SORT] => 55
[CODE] => KEYREPORT2S
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Ключевые выступления
[~DEFAULT_VALUE] =>
)
[PARTICIPANTS] => Array
(
[ID] => 15
[TIMESTAMP_X] => 2017-12-18 10:54:36
[IBLOCK_ID] => 9
[NAME] => Экcперты
[ACTIVE] => Y
[SORT] => 60
[CODE] => PARTICIPANTS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 15
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => Array
(
[0] => 112129
[1] => 112133
[2] => 112134
[3] => 112137
[4] => 118202
[5] => 118203
[6] => 122637
[7] => 122638
[8] => 122639
[9] => 122640
[10] => 122641
)
[VALUE] => Array
(
[0] => Array
(
[ID] => 20536
[NAME] => Игорь Коробко
[DETAIL_PAGE_URL] => /experts/igor-korobko/
[POSITION] => директор Департамента науки, инновационного развития и управления медико- биологическими рисками здоровью Министерства здравоохранения Российской Федерации
[DONOTLINK] =>
[PREVIEW_PICTURE] => 57417
)
[1] => Array
(
[ID] => 20543
[NAME] => Вадим Говорун
[DETAIL_PAGE_URL] => /experts/vadim-govorun/
[POSITION] => директор Федерального научно-клинического центра физико-химической медицины ФМБА России
[DONOTLINK] =>
[PREVIEW_PICTURE] => 57416
)
[2] => Array
(
[ID] => 20557
[NAME] => Этьен Жоусем
[DETAIL_PAGE_URL] => /experts/eten-zhussom/
[POSITION] => руководитель отдела по выводу биомедицинских клеточных продуктов на рынок региона Европа, «Новартис»
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[3] => Array
(
[ID] => 20566
[NAME] => Михаил Масчан
[DETAIL_PAGE_URL] => /experts/mikhail-maschan/
[POSITION] => заместитель генерального директора-директор Высшей школы молекулярной и экспериментальной медицины
[DONOTLINK] =>
[PREVIEW_PICTURE] => 57419
)
[4] => Array
(
[ID] => 21735
[NAME] => Юрий Жулёв
[DETAIL_PAGE_URL] => /experts/yuriy-zhulyev/
[POSITION] => президент Общероссийской благотворительной общественной организации инвалидов «Всероссийское общество гемофилии»
[DONOTLINK] =>
[PREVIEW_PICTURE] => 57574
)
[5] => Array
(
[ID] => 21736
[NAME] => Вадим Меркулов
[DETAIL_PAGE_URL] => /experts/vadim-merkulov/
[POSITION] => заместитель генерального директора ФГБУ «НЦЭСМП» Минздрава России по экспертизе лекарственных средств
[DONOTLINK] =>
[PREVIEW_PICTURE] => 57420
)
[6] => Array
(
[ID] => 21737
[NAME] => Полина Степенски
[DETAIL_PAGE_URL] => /experts/polina-stepenski/
[POSITION] => заведующая отделением трансплантации костного мозга и иммунотерапии у детей и взрослых медицинского центра Хадасса, Израиль
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[7] => Array
(
[ID] => 21738
[NAME] => Сиссель Родаль
[DETAIL_PAGE_URL] => /experts/sissel-rodal/
[POSITION] => генеральный директор по средним европейским странам и России «Авексис»
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
[8] => Array
(
[ID] => 21739
[NAME] => Дмитрий Рождественский
[DETAIL_PAGE_URL] => /experts/dmitriy-rozhdestvenskiy/
[POSITION] => начальник отдела координации работ в сфере обращения лекарственных средств и медицинских изделий Департамента технического регулирования и аккредитации ЕЭК
[DONOTLINK] =>
[PREVIEW_PICTURE] => 57421
)
[9] => Array
(
[ID] => 15473
[NAME] => Евгений Шляхто
[DETAIL_PAGE_URL] => /experts/evgeniy-shlyakhto4021/
[POSITION] => генеральный директор ФГБУ «НМИЦ им. В. А. Алмазова» Министерства здравоохранения Российской Федерации
[DONOTLINK] =>
[PREVIEW_PICTURE] => 36202
)
[10] => Array
(
[ID] => 22172
[NAME] => Кэтрин Тэйлор
[DETAIL_PAGE_URL] => /experts/ketrin-teylor/
[POSITION] => директор по медицинским вопросам на развивающихся рынках региона EMEA, Янссен
[DONOTLINK] =>
[PREVIEW_PICTURE] =>
)
)
[DESCRIPTION] => Array
(
[0] =>
[1] =>
[2] =>
[3] =>
[4] =>
[5] =>
[6] =>
[7] =>
[8] =>
[9] =>
[10] =>
)
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Array
(
[0] => 20536
[1] => 20543
[2] => 20557
[3] => 20566
[4] => 21735
[5] => 21736
[6] => 21737
[7] => 21738
[8] => 21739
[9] => 15473
[10] => 22172
)
[~DESCRIPTION] => Array
(
[0] =>
[1] =>
[2] =>
[3] =>
[4] =>
[5] =>
[6] =>
[7] =>
[8] =>
[9] =>
[10] =>
)
[~NAME] => Экcперты
[~DEFAULT_VALUE] =>
)
[MEMBERS] => Array
(
[ID] => 66
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Участники
[ACTIVE] => Y
[SORT] => 70
[CODE] => MEMBERS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 66
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Участники
[~DEFAULT_VALUE] =>
)
[MEMBERS_AND_EXPERTS] => Array
(
[ID] => 71
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Участники и эксперты
[ACTIVE] => Y
[SORT] => 80
[CODE] => MEMBERS_AND_EXPERTS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 71
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Участники и эксперты
[~DEFAULT_VALUE] =>
)
[KEYREPORT_MODERATOR] => Array
(
[ID] => 73
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Ключевой доклад / модератор
[ACTIVE] => Y
[SORT] => 90
[CODE] => KEYREPORT_MODERATOR
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 73
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Ключевой доклад / модератор
[~DEFAULT_VALUE] =>
)
[SAY_HIS] => Array
(
[ID] => 245
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Приветствие
[ACTIVE] => Y
[SORT] => 91
[CODE] => SAY_HIS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 245
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Приветствие
[~DEFAULT_VALUE] =>
)
[SPEECH] => Array
(
[ID] => 77
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Выступления
[ACTIVE] => Y
[SORT] => 100
[CODE] => SPEECH
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 77
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Выступления
[~DEFAULT_VALUE] =>
)
[DISCUSS_MEMBERS] => Array
(
[ID] => 219
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Участники дискуссии
[ACTIVE] => Y
[SORT] => 101
[CODE] => DISCUSS_MEMBERS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 219
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Участники дискуссии
[~DEFAULT_VALUE] =>
)
[AUTHORS] => Array
(
[ID] => 220
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Авторы
[ACTIVE] => Y
[SORT] => 102
[CODE] => AUTHORS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 220
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Авторы
[~DEFAULT_VALUE] =>
)
[LECTORS] => Array
(
[ID] => 221
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Лекторы
[ACTIVE] => Y
[SORT] => 103
[CODE] => LECTORS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 221
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Лекторы
[~DEFAULT_VALUE] =>
)
[PRESENTATIONS] => Array
(
[ID] => 217
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Презентация
[ACTIVE] => Y
[SORT] => 104
[CODE] => PRESENTATIONS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 217
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Презентация
[~DEFAULT_VALUE] =>
)
[SPEAKERS] => Array
(
[ID] => 231
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Спикеры
[ACTIVE] => Y
[SORT] => 105
[CODE] => SPEAKERS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 231
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Спикеры
[~DEFAULT_VALUE] =>
)
[OPENINGS] => Array
(
[ID] => 240
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Открытие
[ACTIVE] => Y
[SORT] => 106
[CODE] => OPENINGS
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 240
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 8
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Открытие
[~DEFAULT_VALUE] =>
)
[SUBTITLE] => Array
(
[ID] => 75
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Подзаголовок
[ACTIVE] => Y
[SORT] => 110
[CODE] => SUBTITLE
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 75
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 112139
[VALUE] => Эффективное здравоохранение
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Эффективное здравоохранение
[~DESCRIPTION] =>
[~NAME] => Подзаголовок
[~DEFAULT_VALUE] =>
)
[MSP_REPRESENTATIVES] => Array
(
[ID] => 76
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Представители МСП
[ACTIVE] => Y
[SORT] => 120
[CODE] => MSP_REPRESENTATIVES
[DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 76
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] => HTML
[USER_TYPE_SETTINGS] => Array
(
[height] => 200
)
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Представители МСП
[~DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
)
[MEDIA_LINK] => Array
(
[ID] => 118
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Медиаматериалы
[ACTIVE] => Y
[SORT] => 130
[CODE] => MEDIA_LINK
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => E
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 118
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 29
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 138116
[VALUE] => 24286
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => 24286
[~DESCRIPTION] =>
[~NAME] => Медиаматериалы
[~DEFAULT_VALUE] =>
)
[CALENDAR] => Array
(
[ID] => 128
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Календарь
[ACTIVE] => Y
[SORT] => 140
[CODE] => CALENDAR
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] => 128
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Календарь
[~DEFAULT_VALUE] =>
)
[EVENT_INFO] => Array
(
[ID] => 129
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Информационное событие
[ACTIVE] => Y
[SORT] => 150
[CODE] => EVENT_INFO
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] => 129
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Информационное событие
[~DEFAULT_VALUE] =>
)
[CHANGE] => Array
(
[ID] => 130
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Изменение
[ACTIVE] => Y
[SORT] => 160
[CODE] => CHANGE
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] => 130
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Изменение
[~DEFAULT_VALUE] =>
)
[LANGUAGES] => Array
(
[ID] => 222
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Рабочие языки
[ACTIVE] => Y
[SORT] => 170
[CODE] => LANGUAGES
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 222
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => Array
(
[0] => 138117
[1] => 138118
)
[VALUE] => Array
(
[0] => русский
[1] => английский
)
[DESCRIPTION] => Array
(
[0] =>
[1] =>
)
[VALUE_ENUM] => Array
(
[0] => русский
[1] => английский
)
[VALUE_XML_ID] => Array
(
[0] => 1
[1] => 3
)
[VALUE_SORT] => Array
(
[0] => 10
[1] => 30
)
[VALUE_ENUM_ID] => Array
(
[0] => 50
[1] => 52
)
[~VALUE] => Array
(
[0] => русский
[1] => английский
)
[~DESCRIPTION] => Array
(
[0] =>
[1] =>
)
[~NAME] => Рабочие языки
[~DEFAULT_VALUE] =>
)
[INVITATION_ONLY] => Array
(
[ID] => 223
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Вход по индивидуальным приглашениям
[ACTIVE] => Y
[SORT] => 180
[CODE] => INVITATION_ONLY
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] => 223
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Вход по индивидуальным приглашениям
[~DEFAULT_VALUE] =>
)
[PREMIUM_ONLY] => Array
(
[ID] => 232
[TIMESTAMP_X] => 2018-12-13 12:17:20
[IBLOCK_ID] => 9
[NAME] => Вход с бэйджами категории «ПРЕМИУМ»
[ACTIVE] => Y
[SORT] => 500
[CODE] => PREMIUM_ONLY
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => C
[MULTIPLE] => N
[XML_ID] => 232
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[VALUE_ENUM_ID] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Вход с бэйджами категории «ПРЕМИУМ»
[~DEFAULT_VALUE] =>
)
[KEYNOTE_FILE] => Array
(
[ID] => 234
[TIMESTAMP_X] => 2019-01-14 21:27:15
[IBLOCK_ID] => 9
[NAME] => Доклад
[ACTIVE] => Y
[SORT] => 500
[CODE] => KEYNOTE_FILE
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => F
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => Y
[XML_ID] => 234
[FILE_TYPE] => pdf
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => Y
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] =>
[VALUE] =>
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] =>
[~DESCRIPTION] =>
[~NAME] => Доклад
[~DEFAULT_VALUE] =>
)
[EVENT_CATEGORY] => Array
(
[ID] => 297
[TIMESTAMP_X] => 2019-12-22 15:15:18
[IBLOCK_ID] => 9
[NAME] => Категория мероприятия
[ACTIVE] => Y
[SORT] => 500
[CODE] => EVENT_CATEGORY
[DEFAULT_VALUE] =>
[PROPERTY_TYPE] => L
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] =>
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => N
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] =>
[USER_TYPE_SETTINGS] =>
[HINT] =>
[PROPERTY_VALUE_ID] => 138120
[VALUE] => Научно-экспертная программа
[DESCRIPTION] =>
[VALUE_ENUM] => Научно-экспертная программа
[VALUE_XML_ID] => #7fa6cb,#333333
[VALUE_SORT] => 200
[VALUE_ENUM_ID] => 88
[~VALUE] => Научно-экспертная программа
[~DESCRIPTION] =>
[~NAME] => Категория мероприятия
[~DEFAULT_VALUE] =>
)
)
[DISPLAY_PROPERTIES] => Array
(
[QUESTIONS] => Array
(
[ID] => 12
[TIMESTAMP_X] => 2017-12-18 10:54:36
[IBLOCK_ID] => 9
[NAME] => Вопросы для обсуждения
[ACTIVE] => Y
[SORT] => 10
[CODE] => QUESTIONS
[DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
[PROPERTY_TYPE] => S
[ROW_COUNT] => 1
[COL_COUNT] => 30
[LIST_TYPE] => L
[MULTIPLE] => N
[XML_ID] => 12
[FILE_TYPE] =>
[MULTIPLE_CNT] => 5
[TMP_ID] =>
[LINK_IBLOCK_ID] => 0
[WITH_DESCRIPTION] => Y
[SEARCHABLE] => N
[FILTRABLE] => N
[IS_REQUIRED] => N
[VERSION] => 1
[USER_TYPE] => HTML
[USER_TYPE_SETTINGS] => Array
(
[height] => 200
)
[HINT] =>
[PROPERTY_VALUE_ID] => 112126
[VALUE] => Array
(
[TEXT] => <ul class="style-prog-list">
<li>Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.</li>
<li>Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.</li>
</ul>
[TYPE] => HTML
)
[DESCRIPTION] =>
[VALUE_ENUM] =>
[VALUE_XML_ID] =>
[VALUE_SORT] =>
[~VALUE] => Array
(
[TEXT] =>
Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.
Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.
[TYPE] => HTML
)
[~DESCRIPTION] =>
[~NAME] => Вопросы для обсуждения
[~DEFAULT_VALUE] => Array
(
[TYPE] => HTML
[TEXT] =>
)
[DISPLAY_VALUE] =>
Биомедицинские клеточные продукты и высокотехнологичные лекарственные средства: гармонизация понятий в рамках функционирования единого фармацевтического рынка.
Обеспечение государственного финансирования применения генетических технологий в организации медицинской помощи.
В настоящее время в мире происходит стремительное развитие генетических, клеточных и геномных технологий в здравоохранении, включая активное внедрение в клиническую практику генотерапевтических и клеточных препаратов, действие которых направлено на причину возникновения заболевания. Появление такого класса препаратов позволило эффективно бороться с заболеваниями, которые ранее считались неизлечимыми.
Введение в практику и применение инновационных генотерапевтических и клеточных технологий в России затруднено по ряду следующих причин: сложный процесс регистрации, ограниченный доступ пациентов к генетическим методам диагностики, несовершенная система оплаты медицинской помощи. Успешное внедрение инновационных технологий возможно только при активном диалоге между государством и производителем для адаптации нормативно-правового регулирования и дальнейшего обеспечения доступности для пациентов.
Виталий Омельяновский
Игорь Коробко
Вадим Говорун
Этьен Жоусем
Михаил Масчан
Юрий Жулёв
Вадим Меркулов
Дмитрий Рождественский
Евгений Шляхто